[
  {
    "ts": "2026-02-08T05:03:41+00:00",
    "headline": "How Investors May Respond To Elevance Health (ELV) Mixed Results, Softer 2026 Outlook And Higher Payouts",
    "summary": "Elevance Health has reported past fourth-quarter 2025 revenue of US$49,747 million and full-year revenue of US$199.13 billion, with full-year net income easing to US$5,662 million and diluted EPS from continuing operations at US$25.21. Alongside this mixed profit picture, the company signaled a low single digit decline in 2026 operating revenue, while still raising its quarterly dividend to US$1.72 per share and continuing share repurchases. Next, we’ll examine how softer 2026 earnings...",
    "url": "https://finance.yahoo.com/news/investors-may-respond-elevance-health-050341623.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "77593483-58cb-3c80-b9a6-6ee2864ba9a6",
      "content": {
        "id": "77593483-58cb-3c80-b9a6-6ee2864ba9a6",
        "contentType": "STORY",
        "title": "How Investors May Respond To Elevance Health (ELV) Mixed Results, Softer 2026 Outlook And Higher Payouts",
        "description": "",
        "summary": "Elevance Health has reported past fourth-quarter 2025 revenue of US$49,747 million and full-year revenue of US$199.13 billion, with full-year net income easing to US$5,662 million and diluted EPS from continuing operations at US$25.21. Alongside this mixed profit picture, the company signaled a low single digit decline in 2026 operating revenue, while still raising its quarterly dividend to US$1.72 per share and continuing share repurchases. Next, we’ll examine how softer 2026 earnings...",
        "pubDate": "2026-02-08T05:03:41Z",
        "displayTime": "2026-02-08T05:03:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/En2KzBqo8SXnCw89zK0WLw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BoUVqO_whCETSPZRsj9Bbg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/investors-may-respond-elevance-health-050341623.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/investors-may-respond-elevance-health-050341623.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]